Protease Inhibitors

InformationPBD-150 is a human glutaminyl cyclase (hQC) Y115E-Y117E variant inhibitor with Ki of 490 nM.

InformationPBD-150 is a human glutaminyl cyclase (hQC) Y115E-Y117E variant inhibitor with Ki of 490 nM.

Pefabloc SC is a specific, potent, and irreversible inhibitor of serine proteases. The inhibitory activity is comparable to PMSF or DFP, but Pefabloc SC is non-toxic.

PEG4-aminooxy-MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the potent antitubulin agent MMAF, linked via the noncleavable PEG4Form:OilIC50&amp: Target:Auristatin.

PEG4-aminooxy-MMAF is a agent-linker conjugate for ADC with potent antitumor activity by using the potent antitubulin agent MMAF, linked via the noncleavable PEG4Form:OilIC50&amp: Target:Auristatin.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.

Can be used in conjunction with E64-d and Leupeptin A to inhibit the degradation of autophagic cargo inside autophagosomes. For this application, the working concentration is typically between 1-10 μM.An inhibitor of HIV-1 and aspartic proteases.